Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRE and NK cells for advanced pancreatic cancer
NCT02718859Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of NK cell therapy (Anhui Provincial Hospital) in pancreatic cancer (PC), sponsored by Fuda Cancer Hospital. Started Mar 2016; status: completed.
02
Drugs
NK cell therapy (Anhui Provincial Hospital)
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02718859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02718859.